{"id":"W4281779393","doi":"10.1200/jco.2022.40.16_suppl.10025","title":"Progression-free survival and patterns of response in patients with high-risk neuroblastoma (HR-NB) treated with irinotecan/temozolomide/dinutuximab/granulocyte-macrophage colony-stimulating factor (I/T/DIN/GM-CSFS) chemoimmunotherapy.","year":2022,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Neuroblastoma Research and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Medicine; Chemoimmunotherapy; Internal medicine; Oncology; Progression-free survival; Temozolomide; Neuroblastoma; Irinotecan; Immunotherapy; Cancer; Chemotherapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004480671,0.0001911513,0.0003614686,0.0003289168,0.0002851322,0.0004616479,0.0002563779,0.0003915016,0.001044773],"category_scores_gemma":[0.0008258531,0.0002269393,0.0003932851,0.0004028424,0.0002000192,0.0003293822,0.00023812,0.0004182274,0.000249052],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004197303,"about_ca_system_score_gemma":0.0002516099,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001670804,"about_ca_topic_score_gemma":0.001827441,"domain_scores_codex":[0.9998212,0.0000396138,0.00001631239,0.00005670779,0.00002406703,0.0000420417],"domain_scores_gemma":[0.9994844,0.00008293557,0.0002401304,0.00002910582,0.00002779838,0.000135635],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0026377,0.0001572967,0.992875,0.00001244452,0.00007637023,0.0003627439,0.00005395603,0.0001660592,0.001478538,0.00001235957,0.0000883981,0.00207902],"study_design_scores_gemma":[0.0001379603,0.001453557,0.9963237,0.00000487522,0.00006455062,0.0009321668,0.00006237604,0.0004926826,0.0002767035,0.00001966108,0.000226673,0.000005126167],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9996191,0.0001149419,0.00002717045,0.00001139795,0.000001645896,0.000005341334,0.0001335685,0.000001510131,0.00008524221],"genre_scores_gemma":[0.9995659,0.00003959854,0.00002961024,0.00001439552,0.000005075783,0.000008181119,0.0002611616,0.000001039769,0.00007490358],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001670804,"threshold_uncertainty_score":0.003495157,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03405628333367545,"score_gpt":0.3746064941717054,"score_spread":0.34055021083803,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}